Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Botulinum Toxin Type A
Locations
1
South Korea
Dr. Robbin Clinic
Gangnam-gu, Seoul, South Korea
Start Date
September 26, 2014
Primary Completion Date
August 14, 2017
Completion Date
August 14, 2017
Last Updated
July 5, 2019
NCT04985916
NCT06402058
NCT06376838
NCT03911102
NCT04249687
NCT04225260
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions